In this premier episode of Longevity Dialogues, Martin O'Dea interviews Michael Ringel, Chief Operating Officer of Life Biosciences, discussing the evolution of aging research, the potential of epigenetic reprogramming, and the moral and economic arguments for investing in aging research. They explore the challenges of public perception, the importance of awareness, and the future of aging science, emphasizing the need for a collective effort to improve health span and longevity. Hosted on Acast. See acast.com/privacy for more information.
37 分